Article
JAK2V617F mutation is highly prevalent in patients with ischemic stroke: a case-control study.
Blood advances - 10 Oct 2023
Kristiansen Marie Hvelplund, Kjær Lasse, Skov Vibe, Larsen Morten Kranker, Ellervik Christina, Hasselbalch Hans Carl, Wienecke Troels
Abstract excerpt
Ischemic stroke has a high recurrence rate despite treatment. This underlines the significance of investigating new possible cerebrovascular risk factors, such as the acquired gene mutation JAK2V617F found in 3.1% of the general population. We aimed to investigate the prevalence of the JAK2V617F mutation in a population with ischemic stroke compared with that in matched controls. We enrolled 538 consecutive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
